account_balance
Investment manager · 13F filer · SEC CIK 1496201
Sphera Funds Management Ltd.
Reported value$699Mas of Jun 30, 2026
Positions97 22 new, 17 sold out
Top 10 weight36.5%TEVA alone is 7%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
TEVATeva Pharmaceutical Inds Ltd
7.3%Added +32%
MLYSMineralys Therapeutics Inc
5.7%Added +10%
TSEMTower Semiconductor Ltd
4.0%Trimmed −26%
SNDXSyndax Pharmaceuticals Inc
3.2%Added +40%
BIIBBiogen Inc
3.0%Added +4%
RAREUltragenyx Pharmaceutical In
2.8%Trimmed −27%
BMRNBiomarin Pharmaceutical Inc
2.7%Added +135%
CYTKCytokinetics Inc
2.7%Added +452%
BBIOBridgebio Pharma Inc
2.6%
COGTCogent Biosciences Inc
2.5%Added +10%
NVMINova Ltd
2.0%Trimmed −53%
INSMInsmed Inc
1.8%New
TEVATeva Pharmaceutical Inds Ltd
7.3%Added +32%
MLYSMineralys Therapeutics Inc
5.7%Added +10%
TSEMTower Semiconductor Ltd
4.0%Trimmed −26%
SNDXSyndax Pharmaceuticals Inc
3.2%Added +40%
BIIBBiogen Inc
3.0%Added +4%
RARE2.8%BMRN2.7%CYTK2.7%BBIO2.6%COGT2.5%NVMI2.0%INSM1.8%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
TEVA Teva Pharmaceutical Inds Ltd 7.3% Added +32%MLYS Mineralys Therapeutics Inc 5.7% Added +10%TSEM Tower Semiconductor Ltd 4.0% Trimmed −26%SNDX Syndax Pharmaceuticals Inc 3.2% Added +40%BIIB Biogen Inc 3.0% Added +4%RARE Ultragenyx Pharmaceutical In 2.8% Trimmed −27%BMRN Biomarin Pharmaceutical Inc 2.7% Added +135%CYTK Cytokinetics Inc 2.7% Added +452%BBIO Bridgebio Pharma Inc 2.6% HeldCOGT Cogent Biosciences Inc 2.5% Added +10%NVMI Nova Ltd 2.0% Trimmed −53%INSM Insmed Inc 1.8% New
What changed